ProPhase Labs, Inc.
PRPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $883 | $1,247 | $1,431 | -$2,484 |
| % Growth | -29.2% | -12.9% | 157.6% | – |
| Cost of Goods Sold | $1,006 | $513 | $905 | -$3,408 |
| Gross Profit | -$123 | $734 | $526 | $924 |
| % Margin | -13.9% | 58.9% | 36.8% | -37.2% |
| R&D Expenses | $6 | $4 | $97 | $61 |
| G&A Expenses | $0 | $4,624 | $4,092 | $15,430 |
| SG&A Expenses | $4,108 | $4,624 | $4,092 | $15,430 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $528 | $0 | $0 | $0 |
| Operating Expenses | $4,641 | $4,628 | $4,189 | $15,491 |
| Operating Income | -$4,764 | -$3,894 | -$3,663 | -$14,567 |
| % Margin | -539.5% | -312.3% | -256% | 586.4% |
| Other Income/Exp. Net | -$2,232 | $201 | -$1,015 | -$1,397 |
| Pre-Tax Income | -$6,996 | -$3,693 | -$4,678 | -$15,964 |
| Tax Expense | -$157 | $779 | $0 | $14,556 |
| Net Income | -$6,839 | -$4,472 | $3,966 | -$34,359 |
| % Margin | -774.5% | -358.6% | 277.1% | 1,383.2% |
| EPS | -0.16 | -0.11 | 0.21 | -1.58 |
| % Growth | -45.5% | -152.4% | 113.3% | – |
| EPS Diluted | -0.16 | -0.11 | 0.21 | -1.58 |
| Weighted Avg Shares Out | 41,541 | 41,541 | 19,079 | 20,463 |
| Weighted Avg Shares Out Dil | 41,541 | 41,541 | 19,079 | 20,463 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,549 | $587 | $539 | $1,034 |
| Depreciation & Amortization | $1,055 | $1,438 | $1,603 | $613 |
| EBITDA | -$4,392 | -$3,566 | -$2,536 | -$14,317 |
| % Margin | -497.4% | -286% | -177.2% | 576.4% |